Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells

Hiromitsu Watanabe(Hamamatsu University School of Medicine), Hideaki Miyake(Kobe University)

Anticancer Research

July 19, 2021

10.21873/anticanres.15167

Cited by 6

Related Papers

Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell Carcinoma

|Anticancer Research|2020|8

Assessments of therapeutic effects according to timings for combined therapy with axitinib and immune check point inhibitor in a mouse renal cell carcinoma model

|Scientific Reports|2023|7

Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both <i>In Vitro</i> and <i>In Vivo</i>

|In Vivo|2020|3